AR004321A1 - Empleo de epinastina para el tratamiento de dolores. - Google Patents
Empleo de epinastina para el tratamiento de dolores.Info
- Publication number
- AR004321A1 AR004321A1 ARP960105154A ARP960105154A AR004321A1 AR 004321 A1 AR004321 A1 AR 004321A1 AR P960105154 A ARP960105154 A AR P960105154A AR P960105154 A ARP960105154 A AR P960105154A AR 004321 A1 AR004321 A1 AR 004321A1
- Authority
- AR
- Argentina
- Prior art keywords
- epinastine
- pain
- pain treatment
- treatment
- bing
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Pain & Pain Management (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Epidemiology (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
La presente invención se refiere al empleo de epinastina como medicamento para el tratamiento de dolores, en particular de migrana, síndrome de Bing-Horton, dolores de cabeza por tensión, dolores musculares, dolores inflamatorios oneu ralgias.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19542281A DE19542281C2 (de) | 1995-11-14 | 1995-11-14 | Verwendung von Epinastin für die Behandlung der Migräne |
Publications (1)
Publication Number | Publication Date |
---|---|
AR004321A1 true AR004321A1 (es) | 1998-11-04 |
Family
ID=7777343
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP960105154A AR004321A1 (es) | 1995-11-14 | 1996-11-13 | Empleo de epinastina para el tratamiento de dolores. |
Country Status (32)
Country | Link |
---|---|
US (1) | US5942503A (es) |
EP (1) | EP0861081B1 (es) |
JP (2) | JP4264850B2 (es) |
KR (1) | KR100435611B1 (es) |
CN (1) | CN1104242C (es) |
AR (1) | AR004321A1 (es) |
AT (1) | ATE213160T1 (es) |
AU (1) | AU706112B2 (es) |
BG (1) | BG62511B1 (es) |
BR (1) | BR9611502A (es) |
CA (1) | CA2232008C (es) |
CO (1) | CO4770978A1 (es) |
CZ (1) | CZ290115B6 (es) |
DE (2) | DE19542281C2 (es) |
DK (1) | DK0861081T3 (es) |
EE (1) | EE03512B1 (es) |
ES (1) | ES2171746T3 (es) |
HK (1) | HK1015280A1 (es) |
HU (1) | HU225759B1 (es) |
IL (1) | IL123601A (es) |
NO (1) | NO982172L (es) |
NZ (1) | NZ322467A (es) |
PL (1) | PL186615B1 (es) |
PT (1) | PT861081E (es) |
RO (1) | RO118373B1 (es) |
RU (2) | RU2217144C2 (es) |
SK (1) | SK61398A3 (es) |
TR (1) | TR199800853T2 (es) |
TW (1) | TW575423B (es) |
UY (1) | UY24354A1 (es) |
WO (1) | WO1997017971A1 (es) |
ZA (1) | ZA969520B (es) |
Families Citing this family (53)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8022095B2 (en) | 1996-08-16 | 2011-09-20 | Pozen, Inc. | Methods of treating headaches using 5-HT agonists in combination with long-acting NSAIDs |
US6586458B1 (en) | 1996-08-16 | 2003-07-01 | Pozen Inc. | Methods of treating headaches using 5-HT agonists in combination with long-acting NSAIDs |
RS49982B (sr) * | 1997-09-17 | 2008-09-29 | Euro-Celtique S.A., | Sinergistička analgetička kombinacija analgetičkog opijata i inhibitora ciklooksigenaze-2 |
EP1126841B1 (en) * | 1998-11-02 | 2004-12-15 | Merck & Co., Inc. | Combinations of a 5ht1b/1d agonist and a selective cox-2 inhibitor for the treatment of migraine |
AU3596500A (en) * | 1999-02-19 | 2000-09-04 | Pozen, Inc. | Formulation of 5-ht agonists with cox-2 inhibitors |
DE19954516A1 (de) * | 1999-11-12 | 2001-05-17 | Boehringer Ingelheim Int | Epinastin-haltige Lösungen |
DE19958460A1 (de) * | 1999-12-03 | 2001-06-07 | Boehringer Ingelheim Pharma | Verfahren zur Herstellung von Epinastine-Hydrochlorid in der hochschmelzenden Kristallmodifikation |
JP2002087963A (ja) * | 2000-09-08 | 2002-03-27 | Nippon Boehringer Ingelheim Co Ltd | 直接打錠により製造されたエピナスチン含有錠剤 |
DE10152973A1 (de) * | 2001-10-26 | 2003-05-08 | Boehringer Ingelheim Int | Neue trockene und wässrige Epinastin-Sirup-Formulierung |
US20030104017A1 (en) * | 2001-10-26 | 2003-06-05 | Boehringer Ingelheim International Gmbh | Epinastine formulation for oral administration |
CA2494065A1 (en) * | 2002-08-02 | 2004-02-19 | Boehringer Ingelheim International Gmbh | Pharmaceutical formulations comprising combinations of epinastine, pseudoephedrine and methylephedrine |
ATE546134T1 (de) | 2002-12-26 | 2012-03-15 | Pozen Inc | Mehrschichtige dosierformen enthaltend naproxen und triptane |
EP1452177A1 (en) * | 2003-02-27 | 2004-09-01 | Boehringer Ingelheim International GmbH | Pharmaceutical formulations comprising sodium laurylsulfate as bitterness masking agent |
US20090143359A1 (en) * | 2005-07-08 | 2009-06-04 | Akiharu Isowaki | Percutaneously Absorptive Ophthalmic Preparation Comprising Epinastine |
US7247623B2 (en) * | 2005-08-19 | 2007-07-24 | Inspire Pharmaceuticals, Inc. | Method of treating dry eye disease with non-drying antihistamines |
WO2007110380A1 (en) * | 2006-03-25 | 2007-10-04 | Boehringer Ingelheim International Gmbh | Insect bite relief preparation comprising epinastine |
US8536445B2 (en) * | 2006-06-02 | 2013-09-17 | Emcore Solar Power, Inc. | Inverted metamorphic multijunction solar cells |
EP1875899A1 (en) * | 2006-06-29 | 2008-01-09 | Laboratorios Del Dr. Esteve, S.A. | Use of 5HT7 receptor agonists for the treatment of pain |
US20080102097A1 (en) * | 2006-10-31 | 2008-05-01 | Zanella John M | Device and method for treating osteolysis using a drug depot to deliver an anti-inflammatory agent |
US8470360B2 (en) * | 2008-04-18 | 2013-06-25 | Warsaw Orthopedic, Inc. | Drug depots having different release profiles for reducing, preventing or treating pain and inflammation |
RU2464984C2 (ru) * | 2007-11-22 | 2012-10-27 | Общество с ограниченной ответственностью "МС-Вита" | Нестероидное противовоспалительное лекарственное средство |
US8557273B2 (en) * | 2008-04-18 | 2013-10-15 | Medtronic, Inc. | Medical devices and methods including polymers having biologically active agents therein |
US8956641B2 (en) * | 2008-04-18 | 2015-02-17 | Warsaw Orthopedic, Inc. | Alpha adrenergic receptor agonists for treatment of inflammatory diseases |
US20090263451A1 (en) * | 2008-04-18 | 2009-10-22 | Warsaw Orthopedic, Inc. | Anti-Inflammatory and/or Analgesic Agents for Treatment of Myofascial Pain |
USRE48948E1 (en) | 2008-04-18 | 2022-03-01 | Warsaw Orthopedic, Inc. | Clonidine compounds in a biodegradable polymer |
US9610243B2 (en) | 2008-04-18 | 2017-04-04 | Warsaw Orthopedic, Inc. | Clonidine compounds in a biodegradable polymer |
US20090264477A1 (en) * | 2008-04-18 | 2009-10-22 | Warsaw Orthopedic, Inc., An Indiana Corporation | Beta adrenergic receptor agonists for treatment of pain and/or inflammation |
US9072727B2 (en) | 2008-04-18 | 2015-07-07 | Warsaw Orthopedic, Inc. | Alpha adrenergic receptor agonists for treatment of degenerative disc disease |
US8722079B2 (en) * | 2008-04-18 | 2014-05-13 | Warsaw Orthopedic, Inc. | Methods for treating conditions such as dystonia and post-stroke spasticity with clonidine |
US9132119B2 (en) * | 2008-04-18 | 2015-09-15 | Medtronic, Inc. | Clonidine formulation in a polyorthoester carrier |
US9132085B2 (en) | 2008-04-18 | 2015-09-15 | Warsaw Orthopedic, Inc. | Compositions and methods for treating post-operative pain using clonidine and bupivacaine |
US20090264489A1 (en) * | 2008-04-18 | 2009-10-22 | Warsaw Orthopedic, Inc. | Method for Treating Acute Pain with a Formulated Drug Depot in Combination with a Liquid Formulation |
US8889173B2 (en) * | 2008-04-18 | 2014-11-18 | Warsaw Orthopedic, Inc. | Alpha adrenergic receptor agonists for treatment of pain and/or inflammation |
US8420114B2 (en) * | 2008-04-18 | 2013-04-16 | Warsaw Orthopedic, Inc. | Alpha and beta adrenergic receptor agonists for treatment of pain and / or inflammation |
US20090263489A1 (en) * | 2008-04-18 | 2009-10-22 | Warsaw Orthopedic, Inc. | Analgesic and anti-inflammatory compositions and methods for reducing, preventing or treating pain and inflammation |
US8629172B2 (en) | 2008-04-18 | 2014-01-14 | Warsaw Orthopedic, Inc. | Methods and compositions for treating post-operative pain comprising clonidine |
US8883768B2 (en) * | 2008-04-18 | 2014-11-11 | Warsaw Orthopedic, Inc. | Fluocinolone implants to protect against undesirable bone and cartilage destruction |
US8946277B2 (en) | 2008-04-18 | 2015-02-03 | Warsaw Orthopedic, Inc. | Clonidine formulations in a biodegradable polymer carrier |
US20100098746A1 (en) * | 2008-10-20 | 2010-04-22 | Warsaw Orthopedic, Inc. | Compositions and methods for treating periodontal disease comprising clonidine, sulindac and/or fluocinolone |
US8822546B2 (en) * | 2008-12-01 | 2014-09-02 | Medtronic, Inc. | Flowable pharmaceutical depot |
US20100228097A1 (en) * | 2009-03-04 | 2010-09-09 | Warsaw Orthopedic, Inc. | Methods and compositions to diagnose pain |
US20100239632A1 (en) | 2009-03-23 | 2010-09-23 | Warsaw Orthopedic, Inc. | Drug depots for treatment of pain and inflammation in sinus and nasal cavities or cardiac tissue |
US8617583B2 (en) * | 2009-07-17 | 2013-12-31 | Warsaw Orthopedic, Inc. | Alpha adrenergic receptor agonists for prevention or treatment of a hematoma, edema, and/or deep vein thrombosis |
US8231891B2 (en) * | 2009-07-31 | 2012-07-31 | Warsaw Orthopedic, Inc. | Implantable drug depot for weight control |
US20110097375A1 (en) | 2009-10-26 | 2011-04-28 | Warsaw Orthopedic, Inc. | Formulation for preventing or reducing bleeding at a surgical site |
WO2015027296A1 (en) * | 2013-09-02 | 2015-03-05 | The University Of Melbourne | A method of treatment |
CN105708840A (zh) * | 2014-12-01 | 2016-06-29 | 重庆安格龙翔医药科技有限公司 | 一种盐酸依匹斯汀组合物 |
GB2571696B (en) | 2017-10-09 | 2020-05-27 | Compass Pathways Ltd | Large scale method for the preparation of Psilocybin and formulations of Psilocybin so produced |
KR102041389B1 (ko) * | 2017-12-12 | 2019-11-27 | (주)프론트바이오 | N-(9,13b-디하이드로-1H-디벤조[c,f]이미다조[1,5-a]아제핀-3-일)-2-하이드록시벤즈아미드 및 2-((9,13b-디하이드로-1H-디벤조[c,f]이미다조[1,5-a]아제핀-3-일) 카바모일)페닐 아세테이트의 화합물, 이의 제조방법 및 이를 포함하는 항염증 및 진통제 조성물 |
CN114206349A (zh) | 2019-04-17 | 2022-03-18 | 指南针探路者有限公司 | 治疗神经认知障碍、慢性疼痛及减轻炎症的方法 |
JP6963651B2 (ja) * | 2020-04-16 | 2021-11-10 | 参天製薬株式会社 | エピナスチン又はその塩を含有する水性組成物 |
JP7118579B1 (ja) | 2020-04-16 | 2022-08-16 | 参天製薬株式会社 | エピナスチン又はその塩を含有する水性組成物 |
CN115448927A (zh) * | 2022-10-20 | 2022-12-09 | 重庆瑞泊莱医药科技有限公司 | 一种氢溴酸依匹斯汀晶型ii及其制备方法 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3008944A1 (de) * | 1980-03-08 | 1981-09-24 | C.H. Boehringer Sohn, 6507 Ingelheim | Dibenzimidazoazepine, ihre herstellung und verwendung |
-
1995
- 1995-11-14 DE DE19542281A patent/DE19542281C2/de not_active Expired - Fee Related
-
1996
- 1996-10-15 TW TW85112588A patent/TW575423B/zh not_active IP Right Cessation
- 1996-10-24 UY UY24354A patent/UY24354A1/es not_active IP Right Cessation
- 1996-11-13 WO PCT/EP1996/004957 patent/WO1997017971A1/de active IP Right Grant
- 1996-11-13 EP EP96939018A patent/EP0861081B1/de not_active Expired - Lifetime
- 1996-11-13 AT AT96939018T patent/ATE213160T1/de active
- 1996-11-13 BR BR9611502A patent/BR9611502A/pt not_active IP Right Cessation
- 1996-11-13 IL IL12360196A patent/IL123601A/en not_active IP Right Cessation
- 1996-11-13 RO RO98-00922A patent/RO118373B1/ro unknown
- 1996-11-13 DE DE59608738T patent/DE59608738D1/de not_active Expired - Lifetime
- 1996-11-13 US US09/066,392 patent/US5942503A/en not_active Expired - Lifetime
- 1996-11-13 CN CN96198279A patent/CN1104242C/zh not_active Expired - Fee Related
- 1996-11-13 AU AU76230/96A patent/AU706112B2/en not_active Ceased
- 1996-11-13 AR ARP960105154A patent/AR004321A1/es unknown
- 1996-11-13 ES ES96939018T patent/ES2171746T3/es not_active Expired - Lifetime
- 1996-11-13 JP JP51857397A patent/JP4264850B2/ja not_active Expired - Lifetime
- 1996-11-13 SK SK613-98A patent/SK61398A3/sk unknown
- 1996-11-13 RU RU98111639/14A patent/RU2217144C2/ru not_active IP Right Cessation
- 1996-11-13 TR TR1998/00853T patent/TR199800853T2/xx unknown
- 1996-11-13 PT PT96939018T patent/PT861081E/pt unknown
- 1996-11-13 ZA ZA969520A patent/ZA969520B/xx unknown
- 1996-11-13 EE EE9800158A patent/EE03512B1/xx not_active IP Right Cessation
- 1996-11-13 CZ CZ19981498A patent/CZ290115B6/cs not_active IP Right Cessation
- 1996-11-13 DK DK96939018T patent/DK0861081T3/da active
- 1996-11-13 KR KR10-1998-0703549A patent/KR100435611B1/ko not_active IP Right Cessation
- 1996-11-13 NZ NZ322467A patent/NZ322467A/xx not_active IP Right Cessation
- 1996-11-13 PL PL96326653A patent/PL186615B1/pl not_active IP Right Cessation
- 1996-11-13 CA CA002232008A patent/CA2232008C/en not_active Expired - Fee Related
- 1996-11-13 HU HU9903489A patent/HU225759B1/hu not_active IP Right Cessation
- 1996-11-13 RU RU2003101430A patent/RU2238733C2/ru not_active IP Right Cessation
- 1996-11-14 CO CO96060061A patent/CO4770978A1/es unknown
-
1998
- 1998-04-27 BG BG102408A patent/BG62511B1/bg unknown
- 1998-05-13 NO NO982172A patent/NO982172L/no not_active Application Discontinuation
-
1999
- 1999-02-11 HK HK99100562A patent/HK1015280A1/xx not_active IP Right Cessation
-
2008
- 2008-09-01 JP JP2008223046A patent/JP4850880B2/ja not_active Expired - Lifetime
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR004321A1 (es) | Empleo de epinastina para el tratamiento de dolores. | |
BR0314603A (pt) | Uso de inibidores da sìntese de citoquina para o tratamento de distúrbios de olhos secos | |
PT971713E (pt) | Utilizacao de inibidores da colinesterase para tratamento de desordens da atencao | |
PT1143967E (pt) | Utilizacao de derivados anticonvulsivos para o tratamento de cefaleias em salvas | |
CY1106160T1 (el) | Mεταβολιτες βουπροπιονης και μεθοδοι συνθεσης και χρησεις τους | |
ES2181845T3 (es) | Uso de tomoxetina para el tratamiento de la hiperactividad inducida por trastornos de la atencion. | |
TR200000755T2 (tr) | Karşıt olma-karşı gelme bozukluğunun tedavisi. | |
ES2165878T3 (es) | Utilizacion del modafinil para el tratamiento de las apneas del sueño y trastornos de ventilacion de origen central. | |
FR2759581B1 (fr) | Dispositif de traitement, notamment par moxa, de type acupressure | |
AU3831301A (en) | Method for treating ocular pain | |
HK1080467A1 (en) | Benzofuran and benzothiophene derivatives useful in the treatment of hyper-proliferative disorders | |
CY1108808T1 (el) | Ενωσεις μοτιλιδης | |
NZ326754A (en) | The use of 2-amino-4-(4-fluorobenzylamino)-1-ethoxy-carbonylaminobenzene or salts thereof for the prophylaxis and treatment of sequelae of chronic reduced circulation in the brain in particular strokes and for neurodegenerative disorders | |
BR0307951A (pt) | Co-terapia para o tratamento de enxaqueca compreendendo derivados de anticonvulsivantes e agentes antienxaqueca | |
MXPA05002652A (es) | Composicion oralmente administrable para mejorar la calidad de la piel. | |
CY1105482T1 (el) | Χρηση της αζιθρομυκινης στην τοπικη αγωγη οφθαλμικων μολυνσεων | |
BR9911917A (pt) | Composições compreendendo análogos de gaba e cafeìna | |
TR200800693T2 (tr) | Miyelin kaybettiren hastalıkların ya da durumların tedavi yöntemi | |
PL340467A1 (en) | Application of mithrazapin in treating apnoea dissomnia | |
TR200002203T2 (tr) | Lemfotoksin (LT) sentezlenme yolunun inhibitörleri kullanılarak foliküler lemfomaların tedavisi. | |
ES2140887T3 (es) | Procedimiento para cristalizar en agua (s)-n-n'-bis(2-hidroxi-1-(hidroximetil)etil)-5-((2-hidroxi-1-oxopropil)amino)-2,4,6-triyodo-1,3-bencenodicarboxamida. | |
NO20005548D0 (no) | Mykobakterieinhibitorer | |
NO970607D0 (no) | Anordning av selegilin i behandling av epileptiske tilstander | |
BR9915899A (pt) | Composto, composição farmacêutica e método para tratar ou inibir distúrbios associados com contração do músculo liso. | |
BRPI0414423A (pt) | inibidores de pace4, suas composições farmacêuticas e respectivos usos |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |